Phase I study of panobinostat (LBH589) and letrozole in post-menopausal metastatic breast cancer patients
- Citation:
- Clin Breast Cancer vol 16 (2) 82-86
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 5
- Parents:
- 363
- Children:
- None
- Pharmas:
- Grants:
- U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180882, U10 CA180867
- Corr. Author:
- Authors:
- Winston W. Tan Jacob B. Allred Alvaro Moreno-Aspitia Donald W. Northfelt James N. Ingle Matthew P. Goetz Edith A. Perez
- Networks:
- Study
- NCCTG-N093B
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords:
- Phase I, Panobinostat, HDAC inhibitors, metastatic breast cancer, aromatase refractory